Variations of the perforin gene in patients with type 1 diabetes

Diabetes

Volumn 57, Issue 4, 2008, Pages 1078-1083

  Orilieri, Elisabetta ^a   Cappellano, Giuseppe ^a   Clementi, Rita ^a   Cometa, Angela ^b   Ferretti, Massimo ^a   Cerutti, Elisa ^a   Cadario, Francesco ^a   Martinetti, Miryam ^b   Larizza, Daniela ^b   Calcaterra, Valeria ^b   D'Annunzio, Giuseppe ^c   Lorini, Renata ^c   Cerutti, Franco ^d   Bruno, Graziella ^e   Chiocchetti, Annalisa ^a   Dianzani, Umberto ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

^e UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; HLA DQ ANTIGEN; PERFORIN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; PORE FORMING CYTOTOXIC PROTEIN; PRF1 PROTEIN, HUMAN; PRIMER DNA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AUTOIMMUNITY; CELIAC DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CYTOTOXICITY; DISEASE PREDISPOSITION; EXON; FEMALE; GENE; GENE AMPLIFICATION; GENE EXPRESSION; GENE FREQUENCY; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HETEROZYGOTE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTRON; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; N252S GENE; NATURAL KILLER CELL; ONSET AGE; PRIORITY JOURNAL; RISK ASSESSMENT; THYROID GLAND; ADOLESCENT; AMINO ACID SUBSTITUTION; CLINICAL TRIAL; COHORT ANALYSIS; GENETICS; IMMUNOLOGY; ITALY; MULTICENTER STUDY; REFERENCE VALUE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; DNA PRIMERS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HLA-DQ ANTIGENS; HUMANS; ITALY; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PORE FORMING CYTOTOXIC PROTEINS; REFERENCE VALUES; VARIATION (GENETICS);

EID: 42449112039     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db07-0947     Document Type: Article

References (39)

1. Yoon JW, Jun HS: Autoimmune destruction of pancreatic beta cells. Am J Ther 12:580-591, 2005
2. Santamaria P: Effector lymphocytes in autoimmunity. Curr Opin Immunol 13:663-669, 2001
3. Hirschhorn JN: Genetic epidemiology of type 1 diabetes. Pediatr Diabetes 4:87-100, 2003
4. Jahromi MM, Eisenbarth GS: Genetic determinants of type 1 diabetes across populations. Ann N Y Acad Sci 1079:289-99, 2006
5. Wicker LS, Clark J, Fraser HI, Garner VE, Gonzalez-Munoz A, Healy B, Howlett S, Hunter K, Rainbow D, Rosa RL, Smink LJ, Todd JA, Peterson LB: Type 1 diabetes genes and pathways shared by humans and NOD mice. J Autoimmun 25 (Suppl.):29-33, 2005
6. Tivol EA, Borriello F, Schweitzer AN, Lynch WP, Bluestone JA, Sharpe AH: Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3:541-547, 1995
7. Kouki T, Sawai Y, Gardine CA, Fisfalen ME, Alegre ML, DeGroot LJ: CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. The J Immunol 165:6606-6611, 2000
8. Turpeinen H, Laine AP, Hermann R, Simell O, Veijola R, Knip M, Ilonen J: A linkage analysis of the CTLA4 gene region in Finnish patients with type 1 diabetes. Eur J Immunogenet 30:289-293, 2003
9. Marron MP, Raffel LJ, Garchon HJ, Jacob CO, Serrano-Rios M, Martinez Larrad MT, Teng WP, Park Y, Zhang ZX, Goldstein DR, Tao YW, Beaurain G, Bach JF, Huang HS, Luo DF, Zeidler A, Rotter JI, Yang MC, Modilevsky T, Maclaren NK, She JX: Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups. Hum Mol Genet 6:1275-1282, 1997
10. De Franco S, Bonissoni S, Cerutti F, Bona G, Bottarel F, Cadario F, Brusco A, Loffredo G, Rabboni I, Corrias A, Pignata C, Ramenghi U, Dianzani U: Detective function of Fas in patients with type 1 diabetes associated with other autoimmune diseases. Diabetes 50:483-488, 2001
11. Straus SE, Sneller M, Lenardo MJ, Puck JM, Strober W: An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome. Ann Int Med 130:591-601, 1999
12. Sneller MC, Dale JK, Straus SE: Autoimmune lymphoproliferative syndrome. Curr Opin Rheum 15:417-421, 2003
13. Rieux-Laucat F, Le Deist F, Fischer A: Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathway. Cell Death Diff 10:124-133, 2003
14. Dianzani U, Chiocchetti A, Ramenghi U: Role of inherited defects decreasing Fas function in autoimmunity. Life Sciences 72:2803-2824, 2003
15. Trapani JA, Smyth MJ: Functional significance of the perforin/granzyme cell death pathway. Nat Rev Immunol 2:735-747, 2002
16. Su MW, Pyarajan S, Chang JH, Yu CL, Jin YJ, Stierhof YD, Walden P, Burakoff SJ: Fratricide of CD8 + cytotoxic T lymphocytes is dependent on cellular activation and perforin-mediated killing. Eur J Immunol 34:2459-2470, 2004
17. Badovinac VP, Hamilton SE, Harty JT: Viral infection results in massive CD8+ T-cell expansion and mortality in vaccinated perforin-deficient mice. Immunity 18:463-474, 2003
18. Zhou S, Ou R, Huang L, Moskophidis D: Critical role for perforin-, Fas/FasL-, and TNFR1-mediated cytotoxic pathways in down-regulation of antigen-specific T-cells during persistent viral infection. J Virol 76:829-840, 2002
19. Stepp SE, Dufourcq-Lagelouse R, Le Deist F, Bhawan S, Certain S, Mathew PA, Henter JI, Bennett M, Fischer A, de Saint Basile G, Jumar V: Perforingene defects in familial hemophagocytic lymphohistiocytosis. Science 286:957-959, 1999
20. Clementi R, zur Stadt U, Savoldi G, Varoitto S, Conter V, De Fusco C, Notarangelo LD, Schneider M, Klersy C, Janka G, Danesino C, Arico M: Six novel mutations in the PRF1 gene in children with haemophagocytic lymphohistiocytosis. J Med Genet 38:643-646, 2001
21. Ueda I, Morimoto A, Inaba T, Yagi T, Hibi S, Sugimoto T, Sako M, Yanai F, Fukushima T, Nakayama M, Ishii E, Imashuku S: Characteristic perforin gene mutations of haemophagocytic lymphohistiocytosis patients in Japan. Br J Haematol 121:503-510, 2003
22. Feldmann J, Le Deist F, Ouachee-Chardin M, Certain S, Alexander S, Quartier P, Haddad E, Wulffraat N, Casanova JL, Blanche S, Fischer A, de Saint Basile G: Functional consequences of perforin gene mutations in 22 patients with familial haemophagocytic lymphohistiocytosis. Br J Haematol 117:965-972, 2002
23. Fadeel B, Orrenius S, Henter JI: Familial hemophagocytic lymphohistiocytosis: too little cell death can seriously damage your health. Leuk Lymphoma 42:13-20, 2001
24. Feldmann J, Callebaut I, Raposo G, Certain S, Bacq D, Dumont C, Lambert N, Ouachee-Chardin M, Chedeville G, Tamary H, Minard-Colin V, Vilmer E, Blanche S, Le Deist F, Fischer A, de Saint Basile G: Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistocytosis (FHL3). Cell 115:461-473, 2003
25. Clementi R, Dagna L, Dianzani U, Duprè L, Dianzani I, Ponzoni M, Cometa A, Chiocchetti A, Sabbadini MG, Rugarli C, Ciceri F, Maccario R, Locatelli F, Danesino C, Ferrarini M, Bregni M: Inherited perforin and Fas mutations in a patient with autoimmune lymphoproliferative syndrome and lym-phoma. N Engl J Med 351:1419-1424, 2004
26. Clementi R, Chiocchetti A, Cappellano G, Cerutti E, Ferretti M, Orilieri E, Dianzani I, Ferrarini F, Bregni M, Danesino C, Bozzi V, Putti MC, Cerutti F, Cometa A, Locatelli F, Maccario R, Ramenghi U, Dianzani U: Variations of the perforin gene patients with autoimmunity/lymphoproliferation and defective Fas function. Blood 108:3079-3084, 2006
27. Mehta PA, Davies SM, Kumar A, Devidas M, Lee S, Zamzow T, Elliott J, Villanueva J, Pullen J, Zewge Y, Filipovich A: Perforin polymorphism A91V and susceptibility to B-precursor childhood acute lymphoblastic leukaemia: a report from the Children's Oncology group. Leukemia 20:1539-1541, 2006
28. Iafusco D, Stazi MA, Cotichini R, Cotellessa M, Martinucci ME, Mazzella M, Cherubini V, Barbetti F, Martinetti M, Cerutti F, Prisco F; Early Onset Diabetes Study Group of the Italian Society of Paediatric Endocrinology and Diabetology: Permanent diabetes mellitus in the first year of life. Diabetologia 45:798-804, 2002
29. Lipton RB, Kocova M, LaPorte RE, Dorman JS, Orchard TJ, Riley WJ, Drash AL, Becker DJ, Trucco M: Autoimmunity and genetics contribute to the risk of insulin-dependent diabetes mellitus in families: islet cell antibodies and HLA DQ heterodimers. Am J Epidemiol 136:503-512, 1992
30. Molleran Lee S, Villanueva J, Sumegi J, Zhang K, Kogawa K, Davis J, Filipovich AH: Characterisation of diverse PRF1 mutations leading to decreased natural killer cell activity in North American families with haemophagocytic lymphohistiocytosis. J Med Genet 41:137-144, 2004
31. Trambas C, Gallo F, Pende D, Marcenaro S, Moretta L, De Fusco C, Santoro A, Notarangelo L, Arico M, Griffiths GM: A single amino acid change, A91V, leads to conformational changes that can impair processing to the active form of perforin. Blood 106:932-937, 2005
32. Voskoboinik I, Thia MC, Trapani JA: A functional analysis of the putative polymorphisms A91V and N252S and 22 missense perforin mutations associated with familial hemophagocytic lymphohistiocytosis. Blood 105: 4700-4706, 2005
33. Risma KA, Frayer RW, Filipovich AH, Sumegi J: Aberrant maturation of mutant perforin underlies the clinical diversity of hemophagocytic lymphohistiocytosis. J Clin Invest 116:182-192, 2006
34. Bolitho P, Voskoboinik I, Trapani JA, Smith MJ: Apoptosis induced by the lymphocyte effector molecule perforin. Curr Opin immunol 19:339-347, 2007
35. Badovinac VP, Tvinnereim AR, Harty JT: Regulation of antigen-specific CD8+ T-cell homeostasis by perforin and interferon-gamma. Science 290:1354-1358, 2002
36. Marks L, Levy RB: The cytotoxic potential of regulatory T-cells: what has been learned from gene knockout model systems? Transplantation 77: S19-S22, 2004
37. de Saint Basile G, Fischer A: Defective cytotoxic granule-mediated cell death pathway impairs T lymphocyte homeostasis. Curr Opin Rheumatol 15:436-445, 2003
38. Beilke JN, Kuhl NR, Van Kaer L, Gill RG: NK cells promote islet allograft tolerance via a perforin-dependent mechanism. Nat Med 11:1059-1065, 2005
39. Bose A, Inoue Y, Kokko KE, Lakkis FG: Cutting edge: perforin down-regulates CD4 and CD8 T-cell-mediated immune responses to a transplanted organ. J Immunol 170:1611-1614, 2003